All In MedTech

FDA Clearance Tracker · P010039-S003

SONOCUR BASIC EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 27, 2005 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 27, 2005

Approved

Time to decision

334 days

Received Oct 28, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P010039-S003
Device name
SONOCUR BASIC EXTRACORPOREAL SHOCK WAVE THERAPY (ESWT)
Applicant location
Mavern, PA
Received
Oct 28, 2004
Decided
Sep 27, 2005
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P010039

Device type

Device class
Class III

Every decision under product code NBN

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MODIFICATIONS TO THE POST-APPROVAL PROTOCOL.

Source documents

Other decisions for Siemens Medical Solutions USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.